Categories
Healthcare Technology

IoT in healthcare: blockchain use cases and why they matter

Medical IoT devices are great at monitoring patient health and overall fitness. These sleek wearables make it easier to monitor vital signs and help doctors make much faster diagnoses. Connected devices that track pharmaceuticals from reputable sources through the supply chain is also a major opportunity for the healthcare industry. Sounds great right? But with these features, you also need strong guarantees that the data is accurate and untampered with. Blockchain-enabled IoT devices could take advantage of the seamless data exchange IoT offers while also improving healthcare for all.

IoT in healthcare

While IoT devices have been around for a while in many sectors, the rise of wearable — and even ingestible IoT devices are increasingly being put to work in healthcare. As the pace of innovation surges ahead, however, privacy advocates are raising concerns over the data these devices collect. Consumer trust in Big Data is waning as high-profile scandals haunt the big players. Incorporating the trust-building features of blockchain technology may encourage broad adoption of these devices. Blockchain IoT use cases might inject a little more trust into the industry.

Advances in medical technology often mean better tools and more responsive care. In healthcare systems across the world, new tech is helping healthcare professionals deliver better outcomes to their patients. Internet of things devices connect to the internet, collect data, and communicate with each other. In healthcare, these often monitor key health data.

On one hand, IoT medical devices offer patients and doctors new avenues for interaction — and have saved lives. But on the other hand, these devices collect a lot of sensitive data. Security and confidentiality should be top concerns, but many companies have proven incapable of protecting it. Blockchain IoT use cases surrounding robust data protection and integrity can help secure these devices, putting patients in control of who uses this data and for what purpose.

Secure remote patient monitoring

Within the healthcare industry, IoT falls into two categories. These are clinical services and support operations. On the clinical services side, IoT is helping to improve remote patient monitoring, or RPM. RPM features are perhaps the most compelling blockchain IoT use cases in healthcare. Wearable IoT devices also aid clinical trials by tracking vital signs among other indicators such as blood sugar, heart rate or weight.

Swiss medtech startup HIT foundation is already using blockchain technology to facilitate clinical trials, protect medical data, and make sure users know how their data is being used. While it’s not an IoT application per se, one possibility could be to integrate wearable or ingestible IoT devices that continually broadcast patient data during a clinical trial. This would not only provide researchers with verifiable data, but it also gives participants a clear idea of how researchers will use the data and for how long.

With blockchain-enabled IoT devices, end-users can control access to the data the devices collect. By granting and revoking access to sensitive medical data, users can be sure it’s being used appropriately. Blockchain technology in healthcare not only makes medical devices more difficult to hack, but they also can show a detailed record of when another party accesses your data. Consumers concerned with data privacy and companies seeking to better secure their data handling could incorporate blockchain into IoT devices.

Supply chain

Along with more secure remote patient monitoring in medical IoT devices, the drug supply chain is another of several blockchain IoT use cases. Pharma fraud is a major threat to the integrity of the global pharmaceutical industry — and to patient health. Just as you might use a blockchain IoT system to track food provenance, tracking pharmaceuticals through the supply chain would be one possibility for blockchain IoT.

Devices that constantly communicate the location, origin and temperature conditions of pharmaceuticals could have profound impacts on the industry. This would not only reduce waste but would also give regulators and consumers a trustworthy safety guarantee.

In 2018 Swiss Post launched a program using blockchain and IoT that tracks the temperature stability of pharmaceuticals shipped in the mail. The carrier ensures temperature-sensitive drugs such as insulin remain within an acceptable temperature range on its journey to patients. Blockchain technology allows Swiss Post to track the data and also share it with insurers and customers.

iot in healtcare

Establishing trust

Since blockchains keep a tamper-proof record of transactions, it’s much easier to see where your data is going and for how long. Blockchains IoT use cases have clear applications in the medical sector. Blockchain tools can help automate processes in the healthcare sphere. Introducing some transparency between all the stakeholders will improve the industry. More trustworthy sharing of medical data and pharmaceutical supply chains will improve the way patients, doctors, and other stakeholders interact with each other.

As new IoT device manufacturers continue to roll out IoT devices, the need for better data handling is increasingly important. Consumers and privacy watchdogs want to ensure sensitive medical data is properly secured. Blockchain IoT use cases in medtech will do just that.

Conclusion

IoT devices are proliferating in the medtech industry. These devices help medical professionals and patients track their health and monitor vital signs in real-time. IoT devices can also help track pharmaceuticals through the supply chain and verify authenticity. But among the most important blockchain IoT use cases is blockchain’s ability to establish trust in the healthcare industry.

Blockchain’s promise is in its built-in trust mechanism. For IoT devices, this means patients can grant or limit access to their sensitive data, even revoke it if they wish. For ll the complexities of the healthcare market, IoT and blockchain can work together to come up with new ways to make the industry more efficient and responsive to patient needs. It’s up to us to find the best ways to implement it.

Categories
Blockchain Healthcare Technology

What Switzerland can teach the world about blockchain health

Switzerland is one of the leading centers of healthcare R&D in the world. Developments in life sciences on a whole are contributing to a blockchain health niche. When you hear Switzerland, you often associate it with efficiency, precision, and cutting-edge technology. And there’s a very good reason for that. As a global hub of biotech innovation, Switzerland is at the forefront of the blockchain health sector.

Many link Switzerland with finance. But the medical industry is far larger. There is considerable crossover between the two industries. Medtech companies and biotech entrepreneurs took notice of the success of blockchain finance and are looking to blockchain for innovative solutions. For big pharma blockchain lends valuable advantages — ones that Swiss companies are investing in heavily. In this report, I’d like to dig deep into the Swiss life sciences sector and examine how blockchain fits in the larger industry.

Biopharma & blockchain health

Several factors influence Switzerland’s dynamic market development. First, attractive conditions encourage innovation and for international firms to base their operations there. Big players such as Roche and Novartis have headquarters in Basel. In addition, extensive networks of partners, universities, and R&D firms attract a deep talent pool.

According to a report from Swiss Biotech, the number of biotech companies in the medical sector increased by about 65% from 2006-2017. Favorable business conditions, as well as attractive industry development conditions, bolster the Swiss biotech ecosystem. In the years 2015-2017 there was a slight increase in employment in the industry. By 2017 there were about 7,500 employees in private companies and about 6,300 in public companies.

Interestingly, about 80% of companies are small and medium-sized enterprises, which in the case of willingness to establish cooperation usually facilitates the possibility of establishing contact and starting business talks. However, in the years 2006-2017, a stable downward trend occurred in the area of biotechnology industry suppliers. The fact that the number of such entities remains at a similar level is related to the existence of both M&A processes and the increasing involvement of European suppliers on the Swiss market.

The Swiss biotechnology industry is diverse and includes suppliers, service companies, and companies specializing in both product development and manufacturing. The presence of such a broad spectrum of entities in a rather small geographical area is one of the key strengths of Swiss biotechnology.

pharma blockchain

Innosuisse support

Innovative projects in the field of biotechnology are one of the key areas co-financed by Innosuisse, the Swiss Innovation Promotion Agency. This institution focuses on supporting projects with high innovation potential. Its aim is to encourage the SME sector to undertake such projects by offering them financial support in creating international partnerships.

blockchain in heath
Investment capital of biotech companies (CHF)

Innosuisse has a budget of 200 million francs for this purpose. Between 2013 and 2017, 35-47 projects were supported annually, with total funding ranging from 14.4 million to 18.1 million francs per year.

health blockchain
Financial data of biotech companies (CHF)

Financial results of biotechnology companies in Switzerland. According to the analysis of data, the growth of the Swiss biotechnology market observed in recent years took place despite sometimes difficult access to financing such as venture capital or irregular IPOs. This phenomenon was particularly visible in the years 2009-2012.

blockchain in health
Financial data of private biotech companies

Both the public and private sectors in Switzerland have robust revenue and both contribute to the overall dynamism of the Swiss market.

pharma blockchain
Financial data of public biotech companies

MedTech

Such a high level of development of the MedTech market in Switzerland results primarily from access to exceptional research equipment and a highly developed health care system, which stimulates innovation and creates demand for advanced medical technologies.

There are 1,400 companies on the market, consisting of suppliers, service providers, manufacturers, and traders. In addition to global corporations, the Swiss MedTech industry is also made up of many SMEs. 93% of companies employ fewer than 250 people and four out of five companies employ fewer than 50 people. Microenterprises with fewer than ten employees are the largest group.

pharma blockchain
Structure of medtech companies in Switzerland

Such a company structure provides an opportunity for the development of specialized entities or M&A transactions.

The top five Medtech companies in Switzerland:

  • J&J Medical
  • Roche Diagnostics
  • Biotronik
  • Sonova
  • Medtronic

In 2017, Swiss medical device manufacturers invested between 6% and 18% of their turnover – and their suppliers between 5% and 9% in R&D. Nearly 75% of the VC investment in Switzerland in 2017 went to companies in the life science sector. The investment capital of MedTech startups in this period amounted to 87 million CHF.

Below are some numbers describing the MedTech market in Switzerland:

  • 1,400 enterprises
  • 58,500 employees
  • 15.8 bln CHF income
  • 2.3% GDP

Blockchain health

Patent application analysis and research program reports in Switzerland indicate that companies are increasingly active in digitization and data processing technologies, such as blockchain. Blockchain technology is a distributed, decentralized database that enables companies to store information and access it in real time. This technology, if used properly, can improve medtech processes.

Recently, medtech companies have taken an interest in blockchain health data management. One company doing this is the HIT foundation. The company has launched an application that facilitates clinical trials with blockchain. This solution would allow for the creation of a database containing information on each new drugs and the medical records of individual patients taking part in the studies. Pharma blockchain supply chain tracking is also a fascinating trend.

  • The use of blockchain technology to store medical records of patients and other sensitive data on treatment and disease progression, which will enable the acceleration of data exchange between doctors, clinics and other medical facilities;
  • Pharma blockchain supply chain tracking.

Conclusion

Switzerland’s life sciences sector remains among the most dynamic systems in the world. A deep commitment to R&D and investments in that sector boost the industry as a whole. Switzerland definitely can become the brain of Europe, no other European country currently has a better framework for researchers, founders, start-ups, and VCs than Switzerland.

Based on the Swiss Venture Capital Report (2017) in 2016 only 46.8 million Swiss francs was invested in fintech and over than 70% of whole investments, so 570.8 million francs was invested in the life science sector. This number is growing exotentially.

Precision, science-savviness and a drive for excellence in life science research all contribute to the booming of this industry culture here in Switzerland. Investor interest in life science is growing as multinational companies as well as the experts they attract flock here. Myriad interesting projects are emerging from this favorable ecosystem.

Life science, as I have mentioned, is often overshadowed by the much bigger financial sector. However, there are some projects that are implementing Blockchain in this extremely specialized industry and resolving complex problems that impact wider society.

Personally, I believe that Switzerland and especially Basel is the place in the world to invent groundbreaking inventions in blockchain health that will change healthcare for the better.

Categories
Blockchain Software

Swiss medtech startup HIT Foundation puts users in control of health data

Switzerland is a hotbed of medical technology. As Europe’s leading Medtech hub, the Alpine nation hits well above its weight in the sector. Favorable business conditions and a deep talent pool set Switzerland apart as an economic hotspot in the region. Blockchain is sparking intense interest in Medtech. Many blockchain healthcare startups are developing new uses for the technology.

New blockchain use cases in healthcare are emerging in Crypto Valley. One startup working on this is the HIT foundation based in Zug, Switzerland. The company aims to connect clinical researchers with individuals willing to share their medical data. I spoke to CTO Vega Paithankar about the project.


blockchain healthcare startups

Crypto Valley

A 2018 report from Switzerland Global Enterprise cited a serious commitment to R&D as well as proximity to financial centers and VCs as major factors contributing to Switzerland’s outsized influence. From this favorable Swiss ecosystem, blockchain healthcare startups have a place to try new things and develop into global businesses. From pharmaceutical supply chain management to better patient privacy, blockchain healthcare startups are poised to drive innovation in an industry in need of change.

Espeo’s Blockchain Business Development Manager Paweł Sobotkowski agrees and cited precision in medical research as one factor behind the booming Medtech industry in Switzerland.

“Investor interest in medical technology is growing as multinational companies — and the experts they attract flock here,” said Sobotkowski. “Medicine is often overshadowed by the much bigger finance and fintech sector. However, many projects such as HIT Foundation are implementing blockchain in healthcare and resolving complex problems that impact wider society.”


Medtech in Switzerland

As a center of the pharmaceutical industry, research is a top priority for the major players. However, clinical trials increasingly lack a diverse sample group due to a lack of trust over data handling. Medical data researchers collect meanwhile, is difficult to access and not uniform. Siloed data holds medical research back and makes it more expensive to conduct clinical trials. A blockchain platform that rewards users for sharing anonymized medical data promises to change that.


As medical data becomes increasingly digital, the risk of leaked or mishandled sensitive medical data only increases. Swiss blockchain healthcare startup, HIT Foundation has launched an app that connects researchers seeking medical data with people willing to share. In addition to making clinical studies easier to organize, users will realize the value of their medical data and empower them to take back control of it.


Those seeking data can send out a request for medical information and users can control who uses it. HIT foundation uses the NEM blockchain platform to create a space to tokenize and share medical data. The HIT platform also creates a token ecosystem that rewards people who share their data.

I spoke to HIT Foundation CTO Vega Paithankar to get a glimpse inside the startup’s blockchain use cases in healthcare:

What inspired you to get into crypto and the blockchain industry?

I first learned about bitcoin in 2011 while working as a software engineer in California, and I got quite interested in the technology and how it bypasses the problems of digital payment systems — especially when it comes to censorship and cross-border payments.


The idea of decentralized money that’s independent of governments and the banking industry is empowering and has the potential to solve many problems in the world.


Unfortunately, I wasn’t interested enough to actually go and buy any bitcoin at the time. But I still stayed interested in this topic and the more I researched it, the more I realized that was definitely the type of project that I want to be involved in.


What does HIT use blockchain to do?

HIT Foundation is a decentralized marketplace for health information. We use the blockchain as a platform for researchers to say, ‘we’re looking for patients who fit a certain profile.’ We let the user decide whether they agree with the purpose of the request and whether they trust the organization that’s asking for it.

For example, if it’s a university hospital you might be more inclined to contribute your data than if it’s a health insurance or a marketing company. Blockchain is the broadcast medium to send out these requests.

Health information is extremely valuable and privacy-sensitive. As an individual, your health data ought to belong to you, and you should have the right to decide who you share it with, for what purpose, and on what terms. The entire healthcare industry benefits from your data except you, and HIT Foundation aims to change that.

By using the blockchain as a global decentralized platform for posting queries for data, we allow health researchers to reach individuals that fit their desired profile and then reward those individuals who agree to provide their health data.

Which markets are you most active?

Our users come from all parts of the world. We’re working on forming partnerships with healthcare organizations in Switzerland, Vietnam, the US, and are also in talks with NGOs in Western Africa and Central America to use our platform to deliver better healthcare in communities in difficult geographies.

We don’t think health data should be confined to one country if it can benefit you and the state of research. There’s no reason why we should restrict it.

Are there challenges with jurisdiction?

Jurisdiction is an issue for us. Different countries have different regulations surrounding health data protection. However, because we don’t touch the data directly, we don’t even take the risk of mishandling our users’ health data. We don’t take control of it in the first place.

We just connect the seeker and the individual and then at that point, it is the seeker’s responsibility to conform to any regulations on data privacy.

HIT Foundation promises to incentivize patients to share their medical data. How will that work in practice?

We believe that individuals will be motivated to share their data if they are able to exercise their right to consent or not. They’re given complete information about who is requesting the data and for what purpose.

Then it tells you what the incentives are in terms of HIT tokens if you provide answers to all the questions. We don’t actually take control of the data, we don’t put the data anywhere online but instead, we store a cryptographic signature as proof on the blockchain.

If there’s a dispute where the researcher claims that they didn’t get all the answers or the answers were bogus, then both sides can use the cryptographic proof to prove what was sent and what was received. Obviously, if the tokens were sent or not all that proof is on the blockchain.

In the whitepaper, there’s a quote: “tokenizing health data is a revolutionary way to motivate individuals to digitize and share their data.” Could you clarify this?

We’ve found that different people have different reasons and levels of motivation to participate in a system like ours. A lot of people are genuinely excited about blockchain use cases in healthcare.

Many have experienced first hand the power of modern medicine and the need for continuing research to find treatments for terrible diseases. At the same time, people worry about the loss of privacy and of control over their health data, as well as by not seeing the benefits of their contributions.

We are hoping to address these various motivations by paying attention to the control, traceability and even monetary value of health information through tokenization.

What pushback do these types of blockchain use cases in healthcare face? Some may argue that it’s encouraging people to give up valuable data for a small fee.

We have talked to people who have expressed concerns — that we’re asking people to give away their medical data for a few dollars.

And if it were that simple, clearly that’s not something we’d want to do. We see this as more of a token — literally. It’s not supposed to represent the full value of your medical data — at least if you participate in just one study.

One researcher may not pay you what you think your whole medical history is worth. But over time, by tokenizing data, that individual can recognize in real time that researchers value their time, value their privacy, value their right to control and consent to sharing their data.

We expect the monetary part to be one small part of the motivation for individuals. I think the control and the power to decide and actually being able to see and verify where their information is going and for what purpose. That is more likely to motivate people in general.

How will users acquire the HIT tokens? Will they be on exchanges?

Like any other crypto token, it is tradeable peer-to-peer. We expect that at least a few exchanges across the world will list the HIT token. We’ll see whether it will be exchangeable for the official currency or for another cryptocurrency like bitcoin.

However, we don’t expect our users to go in directly and create an account on an exchange. Instead, we hope to build up an ecosystem around this where other players in the health and well-being sector like gyms and health food stores and massage therapists will accept these tokens as full or partial payments for goods and services.

Then those who aggregate these coins will need to have accounts. But that’s actually worth their time because they’d be exchanging potentially thousands of dollars worth of tokens. Or they can turn around and sell them back to other researchers.

Could you elaborate on the platform’s token economy and explain how the two tokens help keep it stable?

So just the mechanics of the token — it’s based on top of the NEM blockchain. It is just a pure utility token, there are no smart contracts or executable code around it. But as I mentioned, we will include things like cryptographic commitments of data to resolve conflicts to an arbiter.

There is a fixed supply of tokens. We reserve 20 or 30% for the development of the protocol and of the system and to incentivize partners to join the platform. But we distribute the bulk of the tokens to users who sign on to our platform.

So if you download the app, you will get a small onboarding bonus. This currently doesn’t have any monetary value. We do expect that as the ecosystem matures, given the finite token supply that it will naturally find a value.

Researchers have to acquire these tokens on the open market based on supply and demand if they want to use our system — which could be hundreds of thousands of users. We hope that it will naturally find a value.

Why did you decide on the NEM platform? What advantages does it offer over other blockchain platforms?

Early on when we started building out our platform, Ethereum was the biggest platform for tokens. The problem was that it had a lot of scalability problems where the transaction fees were very high. Bitcoin was even worse in terms of backlogs and fees.

The whole system was creaky. There was no guarantee that your transaction would go through in a short amount of time. NEM had very aggressive scaling plans. They have very low transaction fees.

It’s more like a proof-of-stake model that could, in theory, lead to centralization. But it’s still an open-source public blockchain. Given their scaling plans, we felt comfortable that we wouldn’t run into the same issues.

Conclusion

Blockchain use cases in healthcare continue to emerge as entrepreneurs come up with ways to use the technology.

HIT foundation not only creates a platform that connects data seekers and data providers, but it also introduces an incentive for people to participate in clinical trials and contribute to medical research.

This blockchain use case will not only make clinical trials easier and cheaper but it will also benefit platform users directly. Switzerland continues to be a hub for blockchain healthcare startups.

The Swiss Medtech sector is among the most advanced in the world and will continue to be a center of new blockchain use cases in healthcare.

Vega will be a panel speaker at an upcoming blockchain meetup on digital health organized by the Swiss-Polish Blockchain Association (of which Espeo is part) on April 11th in Zug. Be sure to join!

Special thanks to Blockchain Business Development Manager for Switzerland and the UK, Paweł Sobotkowski for setting up the interview and for editorial support.

Categories
Entrepreneurship Software

8 reasons to choose Time and Material for Your Software Project

We do things a bit differently here at Espeo. Delivering the highest value to our clients and their end-users is our biggest priority. Based on our experience creating web and mobile apps, we use a time and material model instead of charging a flat rate like many other software houses. Even if it seems counterintuitive, the time and material model is far more effective than flat fees. It will save you money and deliver better quality software.  

Time and material working model is becoming more and more popular and it’s not happening without a reason. This working method and payment model allows you to achieve satisfying results faster, easier, and cheaper than other methods. But let’s start from the beginning!

Time and material agreement is great for when the quantity and scope of work is difficult to determine or when you expect design requirements to change in the middle.

In a time and material agreement, the client agrees to pay the contractor and their subcontractors based on the man-hours they devote multiplied by a fixed rate. This is in contrast to an up-front flat fee.

At first glance, you may think that a fixed price would be safer for a business owner, but nothing is as straightforward in outsourcing software development. Beware companies that spit out a figure quickly. Here’s why:

8 reasons to choose Time and Material for Your Software Project
8 reasons to choose Time and Material for Your Software Project
8 reasons to choose Time and Material for Your Software Project
8 reasons to choose Time and Material for Your Software Project
8 reasons to choose Time and Material for Your Software Project
8 reasons to choose Time and Material for Your Software Project
8 reasons to choose Time and Material for Your Software Project
8 reasons to choose Time and Material for Your Software Project